Bruoha Sharon, Yosefy Chaim, Taha Louay, Dvir Danny, Shuvy Mony, Jubeh Rami, Carasso Shemy, Glikson Michael, Asher Elad
Department of Cardiology, Barzilai Medical Center, The Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.
Jesselson Integrated Heart Center, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
J Clin Med. 2022 Sep 5;11(17):5241. doi: 10.3390/jcm11175241.
Cardiogenic shock complicating acute myocardial infarction is a complex clinical condition associated with dismal prognosis. Routine early target vessel revascularization remains the most effective treatment to substantially improve outcomes, but mortality remains high. Temporary circulatory support devices have emerged with the aim to enhance cardiac unloading and improve end-organ perfusion. However, quality evidence to guide device selection, optimal installation timing, and post-implantation management are scarce, stressing the importance of multidisciplinary expert care. This review focuses on the contemporary use of short-term support devices in the setting of cardiogenic shock following acute myocardial infarction, including the common challenges associated this practice.
急性心肌梗死并发的心源性休克是一种临床情况复杂、预后不佳的病症。常规早期靶血管血运重建仍然是显著改善预后的最有效治疗方法,但死亡率仍然很高。临时循环支持装置应运而生,旨在增强心脏减负并改善终末器官灌注。然而,指导装置选择、最佳安装时机及植入后管理的高质量证据匮乏,凸显了多学科专家护理的重要性。本综述聚焦于急性心肌梗死后心源性休克情况下短期支持装置的当代应用,包括与此种应用相关的常见挑战。